In order to meet the different needs from clinicians and patients, MEDx Translational Medicine (MEDx) has developed a series tests for solid tumors, from large panel NGS tests, to single gene detection assays,FISH and immunohistochemistry (IHC). These tests have been performed on a variety of cancers such as lung cancer, gastrointestinal cancer, breast cancer, thyroid cancer, prostate cancer, and glioma.MEDx has developed many assays to discover potential biomarkers for the diagnosis and prognosis of solid tumors. MEDx intends to help more clinicians understand the clinical significance of all the tests provided and to make every effort to facilitate precision medicine toward the patients.
- About MEDx
- Technology Centers
- Pharma Solutions
-
CDx/IVD Products
IHC-Based AssaysPCR-Based AssaysNGS-Based AssaysMore AssaysCustomized Assays - Clinical Testing
- Quality Systems
- Events
- Contact Us
Home / Clinical Testing / Pan solid tumor
Pan solid tumor
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
PD-L1 | PD-L1（SP263） Testing - TC Interpretation | SP263 Antibody | IHC | 1000001-01 |
PD-L1（SP263） Testing - TC+IC Interpretation | SP263 Antibody | IHC | 1000001-02 | |
PD-L1（22C3） Testing - TPS Interpretation | 22C3 Antibody | IHC | 1000002-01 | |
PD-L1（22C3） Testing - TPS+CPS Interpretation | 22C3 Antibody | IHC | 1000002-03 | |
PD-L1（SP142） Testing - IC Interpretation | SP142 Antibody | IHC | 1000071 | |
PD-L1（E1L3N） Testing - TC Interpretation | E1L3N Antibody | IHC | 1000003-01 | |
PD-L1（E1L3N） Testing - TC+IC Interpretation | E1L3N Antibody | IHC | 1000003-02 | |
PD-L1（E1L3N） Testing - TPS+CPS Interpretation | E1L3N Antibody | IHC | 1000003-03 | |
Tumor Microenvironment | CD3 Protein Expression Detection | 2GV6 Antibody | IHC | 1000069 |
CD4 Protein Expression Detection | SP35 Antibody | IHC | 1000050 | |
CD8 Protein Expression Detection | SP57 Antibody | IHC | 1000051 | |
Multiple Immunohistochemistry（Tricolor） | PDL1+CD4+CD8 | IHC | 1000059 | |
Multiple Immunohistochemistry（Five Standard And Six Colors） | PDL1+CD4+CD8+CD163+PanKeratin | IHC | 1000064 | |
Multiple Immunohistochemistry（Five Standard And Six Colors） | PDL1+CD8+CD68+CD163+FOXP3 | IHC | 1000102 | |
Potential Biomarkers | TROP2 Protein Expression Detection | EPR20043 Antibody | IHC | 1000065 |
LAG3 Protein Expression Detection | 17B4 Antibody | IHC | 1000049 | |
Diagnostic / Predictive / Prognostic Markers | DMMR Testing | MLH1+MLH2+MLH6+PMS2 | IHC | 1000004 |
Microsatellite Instability (MSI) Detection | 5 Loci | PCR+CE | 1000007 | |
Microsatellite Instability (MSI) Detection | 9 Loci | PCR+CE | 1000008 | |
Prediction Markers | Pan-TRK Protein Expression Detection | EPR17341 Antibody | IHC | 1000036 |
NTRK1/2/3 Gene Fusion Detection | Fuse | FISH | 1000035 | |
Gene Detection | Solid Tumors Med1CDx Tissue Detection | 601 Genes | NGS | 1000011 |
Solid Tumor Med1CDx CtDNA Testing | 601 Genes | NGS | 1000012 | |
Solid Tumor OncoCDx Tissue Detection | 191 Genes | NGS | 1000057 | |
Solid Tumor OncoCDx CtDNA Testing | 191 Genes | NGS | 1000058 | |
Solid Tumor MiniCDx Tissue Detection | 95 Genes | NGS | 1000115 | |
Solid Tumor MiniCDx CtDNA Testing | 95 Genes | NGS | 1000116 | |
HRDetectCDx ;Tissue Detection | 85 Genes +41000snp | NGS | 1000075 | |
Homologous Recombination Repair (HRR) Gene Tissue Detection | 14 Genes | NGS | 1000015 | |
Homologous Recombination Repair (HRR) Gene CtDNA Testing | 14 Genes | NGS | 1000056 | |
Whole Exome Sequencing （WES） Tissue Detection | ~27000 Genes | NGS | 1000016 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Prediction Markers | C-MET Protein Expression Detection | D1C2 Antibody | IHC | 1000005 |
C-MET ;Gene Amplification Detection | Amplification | FISH | 1000006 | |
C-MET Gene Exon 14 Skip Detection | Exon14skipping | QPCR | 1000032 | |
ALK Protein Expression Detection | D5F3 Antibody | IHC | 1000103 | |
ALK Gene Fusion Detection | EML4-ALK Fuse | FISH | 1000048 | |
ALK Break Apart | Rearrangement | FISH | 1000068 | |
Gene Detection | Lung Cancer Precise Drug 17 Tissue Gene | 17 Genes | NGS | 1000112 |
Precise Drug Use For Lung Cancer 17ctDNA Gene | 17 Genes | NGS | 1000113 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Gene Detection | Colorectal Cancer Precise Drug Use 14 Gene Tissue Detection | 14 Genes | NGS | 1000089 |
CtDNA Detection Of 14 Gene Of Precise Drug Use In Colorectal Cancer | 14 Genes | NGS | 1000090 | |
58 Gene For Precise Drug Use In Gastric Cancer Tissue Detection | 58 Genes | NGS | 1000095 | |
Detection Of 58 Gene CtDNA Of Precision Drug Use In Gastric Cancer | 58 Genes | NGS | 1000096 | |
28 Gene For Precise Drug Use In Gastrointestinal Stromal Tumors Tissue Detection | 28 Genes | NGS | 1000119 | |
Detection Of CtDNA Of 28 Gene In Gastrointestinal Stromal Tumors | 28 Genes | NGS | 1000120 | |
Esophageal Cancer Precise Drug Use 48 Gene Tissue Detection | 48 Genes | NGS | 1000093 | |
CtDNA Detection Of 48 Gene For Precise Drug Use In Esophageal Cancer | 48 Genes | NGS | 1000094 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Prediction Markers | HER2 Protein Expression Detection | 4B5 Antibody | IHC | 1000067 |
HER2 Gene Amplification Testing | Amplification | FISH | 1000040 | |
Risk Assessment Of Postoperative Recurrence | Breast Cancer 21 Gene | 21 Genes | QPCR | 1000099 |
Gene Detection | Breast Cancer Precise Drug Use 10 Gene Tissue Detection | 10 Genes | NGS | 1000087 |
Precise Detection Of Breast Cancer Using 10 Gene CtDNA | 10 Genes | NGS | 1000088 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Diagnostic / Prognostic Markers | TERT Gene Mutation Detection | TERT | Pyro Sequencing | 1000039 |
Gene Detection | Thyroid Cancer 18 Gene Tissue Detection | 18 Genes | NGS | 1000156 |
Detection Of 18 Gene CtDNA In Thyroid Carcinoma | 18 Genes | NGS | 1000159 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Prediction Markers | AR-V7 Gene Expression Detection | AR-V7 | DdPCR | 1000031 |
• Category | • Tests | • Test Targets | • Test Methods | • Test Code |
Predictive / Prognostic Markers | MGMT Gene Methylation Detection | MGMT | Pyro Sequencing | 1000033 |
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D
Follow MEDx
